Calcimimetic Inhibits Late-Stage Cyst Growth in ADPKD
Open Access
- 1 July 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 20 (7), 1527-1532
- https://doi.org/10.1681/asn.2008090927
Abstract
In polycystic kidney disease (PKD), genetic mutations in polycystin 1 and 2 lead to defective intracellular trafficking of calcium, thereby decreasing intracellular calcium and altering cAMP signaling to favor proliferation. We hypothesized that calcimimetics, allosteric modulators of the calcium-sensing receptor, would reduce cyst growth by increasing intracellular calcium. We randomly assigned 20-wk-old male rats with a form of autosomal dominant PKD (heterozygote Cy/+) to one of four groups for 14 to 18 wk of treatment: (group 1) no treatment; (group 2) calcimimetic R-568 formulated in the diet; (group 3) R-568 plus calcium-supplemented drinking water (R-568 plus Ca); or (group 4) Ca-supplemented drinking water with a normal diet (Ca). Severity of PKD did not progress in any of the three treatment groups between 34 and 38 wk. Compared with no treatment, cyst growth was unaffected at 34 wk by all treatments, but cyst volume and fibrosis were lower at 38 wk, with both R-568-treated groups demonstrating a greater reduction than calcium alone. Between 34 and 38 wk, the total kidney weight increased by 78% in the control group (P < 0.001) and by 19% in the Ca group (P < 0.01), but did not increase in the R-568 or R-568 plus Ca groups, suggesting inhibition of disease progression despite equivalent suppression of parathyroid hormone. In summary, treatment of hyperparathyroidism halts late-stage progression of rodent cystic kidney disease. The benefit of R-568 alone suggests calcium-sensing receptor modulation may have additional inhibitory effects on late-stage cyst growth resulting from a direct modulation of intracellular calcium.Keywords
This publication has 17 references indexed in Scilit:
- Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy/+ ratKidney International, 2008
- Management of Chronic Kidney Disease Mineral-Bone DisorderAdvances in Chronic Kidney Disease, 2007
- Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney diseaseKidney International, 2007
- Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseasesNature Clinical Practice Nephrology, 2006
- Increased Parathyroid Hormone Gene Expression in Secondary Hyperparathyroidism of Experimental Uremia Is Reversed by CalcimimeticsJournal of the American Society of Nephrology, 2006
- Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HClKidney International, 2005
- Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct.JCI Insight, 1997
- Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in ratsAmerican Journal of Kidney Diseases, 1997
- Autosomal-dominant polycystic kidney disease in the ratKidney International, 1993
- In vitro formation and expansion of cysts derived from human renal cortex epithelial cellsKidney International, 1992